openPR Logo
Press release

Pleural Effusions Treatment Market Size, Share, Growth and Trends, Reports 2024-2031

09-05-2024 10:46 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Pleural Effusions Treatment Market || 2024-2031

Pleural Effusions Treatment Market || 2024-2031

Pleural effusions treatment market is estimated to reach at a CAGR of 4.6% during the forecast period (2024-2031).

The pleural effusions treatment market encompasses the medical devices, pharmaceuticals, and therapeutic approaches used to manage and treat pleural effusions-a condition characterized by the accumulation of fluid in the pleural cavity surrounding the lungs. This fluid accumulation can impair breathing and may result from various underlying conditions such as heart failure, infections, or malignancies.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/pleural-effusions-treatment-market

Market Dynamics:

The growing advancement in the therapeutic evaluation of pleural effusions is expected to drive the market growth

Pleural effusion is the accumulation of excess fluid in the pleural space, which can present a diagnostic challenge for physicians as it may be linked to lung or pleural disorders or systemic conditions. Common symptoms include dyspnea, which worsens with exertion, a dry cough, and pleuritic chest pain. Identifying the underlying cause of the pleural effusion is essential for appropriate treatment. In about 20% of cases, the cause remains unidentified. For new or unexplained pleural effusions, thoracocentesis is recommended. Laboratory tests can differentiate between a pleural fluid transudate and an exudate.

Pleurodesis is the preferred method for managing recurrent effusions, but it requires the visceral and parietal pleurae to be in close contact. Cases involving endobronchial tumors, large intrapleural tumor masses, or multiple pleural loculations leading to trapped lungs are less likely to respond to this treatment. If an infection is present alongside the pleural effusion, a thoracotomy may be necessary. This procedure involves a 6- to 8-inch chest incision to remove fibrous tissue and facilitate the drainage of the infected pleural space. Post-surgery, patients will require chest tubes for 2 to 2 weeks to ensure proper fluid drainage.

Segment Covered in the Pleural Effusions Treatment Market:

By Type: Transudative, Exudative.

By Treatment: Thoracentesis, Pleurodesis, Catheter, Pleuroperitoneal Shunt, Others.

By End-User: Hospitals, Clinics, Ambulatory Clinics, Other.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/pleural-effusions-treatment-market

Key players involved in Pleural Effusions Treatment Market:

• B. Braun Melsungen
• Becton, Dickinson and Company
• Bearpac Medical
• Biometrix
• Cook Medical
• Grena
• Redax
• Rocket Medical
• Smith Medical
• Pfm Medical AG

Related Reports:

Photonics Market: https://www.datamintelligence.com/research-report/photonics-market

Medical Oxygen Market: https://www.datamintelligence.com/research-report/medical-oxygen-market

Organ Preservation Market: https://www.datamintelligence.com/research-report/organ-preservation-market

Product Portfolio:

B. Braun Melsungen

B. Braun Melsungen AG is a leading German medical and pharmaceutical device company headquartered in Melsungen, Germany. With a global presence spanning over 60 countries, the company employs more than 63,000 people worldwide. B. Braun specializes in a range of medical devices and services, demonstrating a strong commitment to advancing healthcare through innovation and high-quality products.

Regional Analysis:

The global Pleural Effusions Treatment Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Pleural Effusions Treatment Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pleural Effusions Treatment Market Size, Share, Growth and Trends, Reports 2024-2031 here

News-ID: 3646244 • Views:

More Releases from DataM Intelligence 4Market Research

United States Peripheral Neuropathy Market Set for Transformative Growth with Rising Treatment Innovations 2025 | Top key players - GlaxoSmithKline, Abbott Laboratories, Cipla Laboratories.
United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth: The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031). The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancements in Treatment & Rising Cardiovascular Cases 2025 | Top key players - Merck, Novartis, Amgen Inc.
United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth: The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031. The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and Rising Patient Demand 2025 | Top key players - AdvaCare Pharma, Sanofi, Pfizer Inc.
United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth: The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033. The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth with Innovative Therapies Revolutionizing Oncology Care 2025 | Major key players - BioNTech SE, Merck & Co., Inc., Moderna, Inc.
United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth: The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033. The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in

All 5 Releases


More Releases for Pleural

Pleural Effusion Market Emerging Trends and Growth Prospects 2034
Introduction Pleural effusion, a condition characterized by the accumulation of excess fluid in the pleural cavity, often results from underlying diseases such as malignant tumors, heart failure, and infections. This condition can significantly impair respiratory function and lead to symptoms like shortness of breath, chest pain, and coughing. The global burden of pleural effusion is rising, particularly due to the increasing prevalence of lung cancer, heart disease, and chronic respiratory diseases. The
Malignant Pleural Effusion Pipeline Therapeutics Assessment Report 2024 (Updated …
DelveInsight's, "Malignant Pleural Effusion Pipeline Insight 2024" report provides comprehensive insights about 8+ companies and 8+ pipeline drugs in Malignant Pleural Effusion pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Explore our latest breakthroughs in Malignant Pleural Effusion Research.
Pleural Drainage Catheters Market Size 2024 to 2031.
Market Overview and Report Coverage A Pleural Drainage Catheter is a medical device used to drain fluid or air from the pleural cavity surrounding the lungs. These catheters are commonly used in patients suffering from conditions such as pneumonia, lung cancer, or pleural effusion. The Pleural Drainage Catheters Market is expected to witness significant growth in the coming years, with a projected CAGR of 7.80% during the forecasted period. This
Pleural Drainage Catheters Market Will Generate Record Revenue by 2031
Pleural Drainage Catheters Market size was valued at USD billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 14.88% from 2024 to 2030. The Pleural Drainage Catheters Market is witnessing a significant surge, driven by a myriad of factors including the rising prevalence of respiratory disorders, advancements in catheter technology, and increasing demand for minimally invasive treatment options. This article explores the latest
Global Pleural Effusion Drug Market - Industry Trends and Forecast to 2028
Global Pleural Effusion Drug Market - Industry Trends and Forecast to 2028 The pleural effusion drug market is expected to gain market growth at a potential rate of 4.70% in the forecast period of 2021 to 2028. Increase in prevalence rate of pleural effusion worldwide is the vital factor escalating the pleural effusion drug market growth. Pleural effusion is a type of condition in which excessive fluids build-up or accumulates in the
12-09-2021 | Health & Medicine
Fact.MR
Malignant Pleural Effusions to Gain Maximum Traction in Pleural Catheters Market …
250 Pages Pleural Catheters Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider According to Fact MR’s recent market research, sales of Pleural Catheters to swell at propelled CAGR through 2031, as investment towards expansion of healthcare infrastructure continues rising. The goal of the survey is uncover growth opportunities, key trends, growth drivers, and challenges. It also provides recommendations to assist businesses in preparing for unforeseen challenges. Focus on